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SUMMARY
Hippocampal neurogenesis is important for certain
forms of cognition, and failing neurogenesis has
been implicated in neuropsychiatric diseases. The
neurogenic capacity of hippocampal neural stem/
progenitor cells (NSPCs) depends on a balance
between quiescent and proliferative states. Here,
we show that the rate of fatty acid oxidation (FAO)
regulates the activity of NSPCs. Quiescent NSPCs
show high levels of carnitine palmitoyltransferase
1a (Cpt1a)-dependent FAO, which is downregulated
in proliferating NSPCs. Pharmacological inhibition
and conditional deletion of Cpt1a in vitro and in vivo
leads to altered NSPC behavior, showing that Cpt1a-
dependent FAO is required for stem cell maintenance
and proper neurogenesis. Strikingly, manipulation of
malonyl-CoA, the metabolite that regulates levels of
FAO, is sufficient to induce exit from quiescence
and to enhance NSPC proliferation. Thus, the data
presented here identify a shift in FAO metabolism
that governs NSPC behavior and suggest an instruc-
tive role for fatty acid metabolism in regulating NSPC
activity.
INTRODUCTION
New neurons are generated throughout life in the mammalian
hippocampus (Spalding et al., 2013; van Praag et al., 2002).
This process, called adult neurogenesis, is critically involved
in a variety of hippocampus-dependent forms of learning and
memory (Clelland et al., 2009; Deng et al., 2010; Dupret
et al., 2008; Gonc¸alves et al., 2016; Nakashiba et al., 2012;
Sahay et al., 2011a, 2011b). In addition, failing or altered neuro-
genesis has been associated with a number of neuropsychi-
atric diseases, such as major depression, epilepsy, and cogni-
tive aging, suggesting adult hippocampal neurogenesis is
relevant for human health and disease (Christian et al., 2014;
Kempermann et al., 2008; Scharfman and Hen, 2007). Neural
stem/progenitor cells (NSPCs) in the adult hippocampus reside
in the subgranular zone (SGZ) of the dentate gyrus (DG), where
they proliferate and generate new glutamatergic, excitatory
granule cells that become integrated into pre-existing cir-
cuitries over the course of several weeks (Espo´sito et al.,
2005; Ge et al., 2007; Lagace et al., 2007; Seri et al., 2001;
Toni et al., 2008; Zhao et al., 2006). Previous reports have sug-
gested a delicate balance between quiescent, radial glia-like
NSPCs and more proliferative NSPCs controlled by key
signaling pathways, such as Notch and BMP signaling, resem-
bling molecular mechanisms identified in the developing brain
(Ables et al., 2010; Ehm et al., 2010; Lugert et al., 2010; Ming
and Song, 2011; Mira et al., 2010). In addition, accumulating
evidence in NSPCs and other somatic stem cells, such as
hematopoietic stem cells (HSCs), has suggested that cellular
metabolism might govern the levels of activity of adult stem
cells in vivo and during cellular reprogramming in vitro (Chorna
et al., 2013; David, 2011; Folmes et al., 2011; Homem et al.,
2015; Ito et al., 2012; Ito and Suda, 2014; Knobloch et al.,
2013; Ryall et al., 2015). However, whether specific metabolic
programs regulate the balance between NSPC quiescence
and proliferation remains unknown. The brain is the organ
with the highest glucose consumption rate (Mergenthaler
et al., 2013), and neurons are mainly dependent on glucose
and lactate for normal function. The role of lipids in brain meta-
bolism has been much less studied, given the predominance of
glucose consumption. Furthermore, the relatively small propor-
tion of NSPCs compared to the cellular mass of the brain might
have led to the overlooking of other metabolic pathways
relevant for NSPCs. Indeed, we have previously identified an
important role for lipid metabolism in NSPCs, showing that
the build-up of lipids through de novo lipogenesis is crucial
for proliferation (Knobloch et al., 2013). However, whether the
metabolic counterpart, the breakdown of lipids called fatty
acid oxidation (FAO), is important to regulate NSPC behavior
remains poorly understood. We here characterized metabolic
adaptations from a quiescent to an activated NSPC state and
identified FAO as a key metabolic pathway to regulate NSPC
quiescence.
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RESULTS
Quiescent NSPCs Have High Levels of FAO
To studymetabolic adaptations during NSPC quiescence versus
activation, we modified previously established in vitro protocols
that are based on the induction of NSPC quiescence by bone
morphogenic protein 4 (BMP4), leading to cellular quiescence
over the course of three days (Figure 1A) (Martynoga et al.,
2013; Mira et al., 2010). BMP4-induced quiescence was revers-
ible with restored proliferation and differentiation potential after
removal of quiescence cues, suggesting a reliable in vitro model
of functional NSPC quiescence (Figures S1A–S1C). We first
analyzed thewhole proteome of proliferating compared to quies-
cent NSPCs and found proteins associated with FAO (the break-
down of fatty acids into acetyl-coenzyme A [CoA] in the
mitochondria) to be highly enriched in quiescent NSPCs (Figures
1B and S1D–S1F; Tables S1 and S2). To test whether the high
expression levels of proteins associated with FAO translate
into functionally elevated levels of FAO, we used radioactive
FAO measurements. A labeled fatty acid (3H-palmitic acid) was
added to the medium. During oxidation of such labeled palmitic
acid into eight acetyl-CoAs, measurable radioactive labeled
water (3H2O) is produced, which serves as a readout of the
rate of FAO. Strikingly, we found high levels of FAO in quiescent
NSPCs that were substantially lower in proliferating NSPCs
(Figure 1C).
To characterize FAO in quiescent NSPCs, we analyzed the
expression of carnitine palmitoyltransferase 1a (Cpt1a), a rate-
limiting mitochondrial enzyme of FAO that mediates the trans-
port of fatty acids into the mitochondria (Houten and Wanders,
2010). Corroborating the proteomics data, we found strong
upregulation of Cpt1a using qRT-PCR and western blot ana-
lyses, showing a substantial increase in the expression of
Cpt1a in quiescent compared to proliferating NSPCs (Figures
1D and 1E). In line with the radioactive FAO measurements,
the increase in Cpt1a expression in quiescent NSPCs was
reversible (Figure 1D). Cpt1a co-labeled with the mitochondrial
dye Mitotracker in both quiescent and proliferating NSPCs (Fig-
ures 1H and S1H). In addition, Cpt1a was highly expressed in
NSPCs compared to their neuronal progeny when directly
isolated from the adult DG (3.5-fold upregulated in SOX2+ cells
versus DCX+ cells), as described previously (Bracko et al.,
2012; Shin et al., 2015). Collectively, these data indicate that
compared to proliferating NSPCs that are highly lipogenic (Kno-
bloch et al., 2013), quiescent NSPCs strongly express Cpt1a and
show high levels of functional FAO.
Next, we aimed to understand the molecular mechanism
underlying high levels of FAO in quiescent NSPCs. We have pre-
viously shown that Spot14 is selectively expressed in quiescent
NSPCs in vivo (Knobloch et al., 2013, 2014). When we induced
quiescence in vitro, we found a >30-fold upregulation of
Spot14 mRNA using qRT-PCR (Figure 1F). Given that Spot14
negatively regulates malonyl-CoA levels (Colbert et al., 2010;
Knobloch et al., 2013), we expected that high levels of Spot14
in quiescent NSPCs would lead to low levels of malonyl-CoA.
Indeed, quiescent NSPCs showed a substantial decrease in
malonyl-CoA, as measured with mass spectrometry (Figure 1G).
The levels of acetyl-CoA, which are not affected by Spot14, were
comparable between proliferating and quiescent NSPCs
(Figure S1G). Because malonyl-CoA is an endogenous inhibitor
of Cpt1a, its levels determine the rate of FAO (Folmes et al.,
2013; Houten and Wanders, 2010). Thus, high levels of Spot14
accompanied by low levels of malonyl-CoA in quiescent NSPCs
promote high FAO (see also summary scheme Figure 5E).
High Levels of FAO Are Required to Sustain Cellular
Quiescence
To test for the functional relevance of FAO activity, we blocked
FAO in quiescent NSPCs using the irreversible Cpt1 inhibitor
Etomoxir. NSPCs were induced to quiescence and then
exposed to various doses of Etomoxir. Cell survival was
assessed using time-lapse imaging. Strikingly, such complete
FAO inhibition in quiescent NSPCs led to massive cell death in
a dose-dependent manner (Figure 2A). This finding indicates
that FAO is critically involved in maintaining adult hippocampal
NSPCs in a quiescent state and that absence of this pathway
is detrimental. Complete blockage of FAO using Etomoxir also
affected NSPCs kept under proliferating conditions by reducing
their proliferation, as assessed by time-lapse imaging, flow
cytometry analysis, and 5-ethynyl-2’-deoxyuridine (EdU)-pulse
labeling (Figures S2A–S2C). These findings are in line with a
recent report showing that proliferating NSPCs in the SVZ can
oxidize fatty acids (Stoll et al., 2015). Given the detectable levels
of FAO in proliferating NSPCs, (although much lower than in
quiescent NSPCs; Figure 1C) and the effect of blocking FAO
on proliferation, these data suggest that FAO is still to a certain
extend relevant during proliferation. However, in contrast to
quiescent NSPCs, abolishing FAO in proliferating NSPCs only
mildly affected their cell survival (Figures S2A–S2C).
Given the importance of FAO for NSPC behavior in vitro, we
next investigated why quiescent NSPCs require FAO. We used
two complementary approaches to analyze the fate of oxidized
fatty acids in NSPCs. First, we used radioactively labeled
14C-palmitic acid to determine the complete oxidation of fatty
acids, allowing for energy production. In contrast to the 3H-pal-
mitic acid labeling, where radioactive labeled 3H2O is produced
during the entire oxidation cycles into acetyl-CoAs, radioactively
labeled 14C-palmitic acid yields measureable 14CO2 only if the
resulting acetyl-CoAs are further oxidized in the tricarboxylic
acid (TCA) cycle. We found significantly higher levels of 14CO2
in quiescent NSPCs compared to proliferating NSPCs, suggest-
ing that quiescent NSPCs might use fatty acids as a fuel source
(Figure 2B). To confirm that quiescent NSPCs use FAO for
energy production, we determined their energy charge, as a
readout for the amount of energy available in the form of adeno-
sine triphosphate (ATP). We found that the energy charge signif-
icantly dropped following Etomoxir treatment, indicating that
FAO is indeed contributing to the amount of ATP generated in
quiescent NSPCs (Figure 2C), with the massive drop using
200 mm Etomoxir probably indicating reduced cell viability.
Next, we used 13C-labeled palmitic acid to trace the incorpo-
ration of labeled carbon atoms in quiescent versus proliferative
NSPCs (Figure 2D). During complete oxidation of such labeled
palmitic acid, labeled carbon atoms are cleaved off and trans-
ferred to TCA intermediates and amino acids derived from TCA
intermediates. The amount of incorporation of labeled carbons
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Figure 1. Quiescent NSPCs Have a High Rate of FAO
(A) Exposure of NSPCs to a BMP4-containing quiescencemedium for three days leads to amassive decrease in proliferation. Shown are representative images of
proliferating (prol) and quiescent (quie) NSPCs and quantification of the mitotic cell marker phospho histone 3 (pH3) (mean ± SEM).
(B) Mass spectrometric comparison of the proteome of proliferating and quiescent NSPCs reveals FAO to be enriched in quiescent NSPCs. The histogram shows
the normalized abundance of proteins belonging to the GO term ‘‘Fatty acid oxidation’’ (gray = expression change of log2 < j1j, red = expression change of
log2% 1, enriched in quiescent cells).
(C) Radioactive FAOmeasurements using 3H-labeled palmitic acid revealed a significant increase in the rate of FAO in quiescent NSPCs compared to proliferating
NSPCs. Remarkably, this increase was reversed in quiescent NSPCs that had been re-exposed to proliferation conditions (ex quie), suggesting FAO is spe-
cifically upregulated upon quiescence entry (mean ± SD).
(D) mRNA levels of the key FAO enzyme Cpt1a are highly and reversibly upregulated in quiescent (quie) NSPCs compared to proliferating (prol) and formerly
quiescent (ex quie) NSPCs (mean ± SEM).
(E) The increase in Cpt1a mRNA levels is also reflected on protein levels, as revealed by western blot analysis (mean ± SEM).
(F) mRNA levels of the previously described novel quiescence marker Spot14 are highly upregulated in quiescent (quie) NSPCs compared to proliferating (prol)
NSPCs. This upregulation is reversible, as formerly quiescent (ex quie) NSPCs greatly reduce Spot14 mRNA levels. This suggests that the BMP4-induced in vitro
quiescence system indeed reflects features of in vivo NSPC quiescence (mean ± SEM).
(G) The endogenous Cpt1a inhibitor malonyl-CoA is lowered in quiescent NSPCs compared to proliferating NSPCs, as measured by mass spectrometry analysis
(mean ± SEM).
(H) Co-stainings against Cpt1a and a mitochondrial marker (Mitotracker) reveals the mitochondrial localization of Cpt1a in quiescent NSPCs. Shown is a
representative confocal image of maximum projections of individual channels and a 3D reconstruction.
Scale bars represent 50 mm (A) and 20 mm (H). ***p < 0.001; **p < 0.01.
See also Figure S1.
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can be measured using mass spectrometry. We found highly
significant increases in the incorporation of 13C into TCA inter-
mediates as well as into amino acids derived from TCA interme-
diates in quiescent NSPCs (Figure 2E), suggesting that the fatty
acid-derived carbon atoms might be further used as an alterna-
tive carbon source.
To address whether the upregulation of FAO in quiescent
NSPCs is transcriptionally regulated, we measured the expres-
sion levels of the Peroxisome proliferator-activated receptor
alpha (PPARa), a known transcriptional regulator of genes
involved in FAO by qRT-PCR (Leone et al., 1999). Indeed,
expression of PPARa and its target genes was highly upregu-
lated in quiescent NSPCs compared to proliferating NSPCs (Fig-
ures 2G and S2D), suggesting that upregulation of FAO upon
quiescence is at least partially regulated on a transcriptional
level. Given this transcriptional component of FAO regulation
Figure 2. High Levels of FAO Are Required to Sustain Cellular Quiescence
(A)Time-lapseanalysisofquiescentNSPCsexposed tovariousdosesof the irreversibleCpt1 inhibitor Etomoxir (50, 100,and200mM).Shownarea schematicoutline
of the experimental setup, the quantification of the area covered by quiescent NSPCs over time, and representative images. Complete block of FAO by Etomoxir
during quiescence leads to a dramatic and dose-dependent decrease of area covered over time, caused by cell death upon FAO inhibition (mean ± SEM).
(B–E) Quiescent NSPCs use FAO for energy purposes and may use it as an alternative carbon source.
(B) Radioactive FAO measurements using 14C-labeled palmitic acid revealed a significant increase in 14CO2 in quiescent NSPCs compared to proliferating
NSPCs, suggesting that at least part of the fatty acids are fully oxidized and might be used for energy purposes (mean ± SD).
(C) Energy charge measurements in quiescent NSPCs show that FAO indeed contributes to the amount of ATP generated, as treatment with various doses of
Etomoxir (50, 100, and 200 mM) reduced the energy charge significantly (mean ± SEM).
(D) Scheme outlining the path of 13C-labeled palmitic acid upon FAO. The oxidation of fatty acids results in acetyl-CoA, which can be fed into the TCA. The
metabolites measured with mass spectrometry in a 13C-incorporation assay are shown in bold.
(E) Quiescent NSPCs show an increase in 13C-incorporation in TCA intermediates and amino acids derived from TCA intermediates compared to proliferating
NSPCs (mean ± SD). These 13C-incorporation assay results suggest that fatty acids might also serve as an alternative carbon source in quiescent NSPCs.
(F) High levels of FAO in quiescent NSPCs are at least partially regulated through the transcription factor PPARa. Treatment for 48 hr with 100 mM of the PPARa
agonist WY14643 in proliferating NSPCs significantly reduced proliferation compared to control NSPCs, but proliferation was still far higher than in quiescent
NSPCs, as assessed by EdU pulsing. Shown are representative images and the corresponding quantification of EdU-positive cells (mean ± SEM).
(G) WY14643 treatment led to an upregulation of PPARa and its target FAO genes in proliferating NSPCs compared to control NSPCs, however, to a far lesser
extent than in quiescent NSPCs. Shown are the mRNA expression levels (mean fold change ± range) of PPARa, Peroxisome proliferator-activated receptor
gamma coactivator 1-alpha (PGC1a), Cpt1a, medium-chain acyl-CoA dehydrogenase (Acadm), long-chain acyl-CoA dehydrogenase (Acadl), and very long-
chain acyl-CoA dehydrogenase (Acadvl).
Scale bar represents 50 mm (A) and 20 mm (F). ***p < 0.001; **p < 0.01.
See also Figure S2 and Table S3.
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through PPARa, we next assessed whether FAO gene expres-
sion could be modulated in proliferating NSPCs to reach similar
levels as in quiescent NSPCs and whether such an upregulation
would render proliferating NSPCs more quiescent. Treatment
with the PPARa agonist WY14643 indeed led to an upregulation
of FAO genes in proliferating NSPCs compared to control
NSPCs (Figure 2G and S2D), however, to a far lesser extent
than in quiescent NSPCs. Similarly, although modulation of
FAO genes by WY14643 significantly reduced proliferation
compared to control NSPCs, proliferation was still far higher
than in quiescent NSPCs (Figure 2F).
Cpt1a Is Expressed in Hippocampal NSPCs In Vivo
After identifying a role for FAO in NSPC quiescence in vitro, we
next analyzed the expression of Cpt1a within the adult hippo-
campal neurogenic niche using a Cpt1a reporter mouse
expressing GFP from the regulatory elements of the Cpt1a
genomic locus (Genesat; hereafter called Cpt1a-GFP) (Gong
et al., 2003). Besides GFP-positive classical astrocytes
throughout all hippocampal subfields (Figures 3A and S3B), we
found GFP expression to be highly enriched in the subgranular
zone (SGZ) of the DG (Figures 3A and S3A). GFP-positive cells
expressed Cpt1a, as confirmed with staining against endoge-
nous Cpt1a (Figure S3C). Next, we phenotyped GFP-labeled
cells in Cpt1a-GFP mice and found that GFP expression prefer-
entially labeled non-mitotic, Ki67-negative hippocampal NSPCs
and only a small subset of cycling NSPCs (Figure 3B). Virtually all
Cpt1a-GFP-positive cells co-labeled with the radial and non-
radial NSPCmarker SOX2 (Figure 3C). Furthermore, the majority
of radial processes positive for the radial NSPC marker Nestin
were also GFP positive (83.7% ± 6.2%; Figure 3C). Cpt1a was
virtually absent in doublecortin (DCX)-expressing neuronal prog-
eny of hippocampal NSPCs (Figure 3D). Furthermore, Spot14
was co-expressed in Cpt1a-GFP-positive cells (Figures S3D
and S3E), suggesting that FAO is indeed high in NSPCs and be-
comes downregulated with neuronal differentiation.
Cpt1a Is Required for Proper Neurogenesis In Vivo
To directly test for a role of Cpt1a-dependent FAO for NSPCs
in vivo, we conditionally deleted Cpt1a specifically in adult quies-
cent NSPCs by crossing Cpt1a flox/flox mice (Cpt1a-conditional
knockout [cKO]) (Schoors et al., 2015) with mice harboring
tamoxifen (TAM)-inducible Spot14-driven Cre recombinase
(S14iCre) (Knobloch et al., 2013) and yellow fluorescent protein
Figure 3. Cpt1a Is Expressed in Adult
NSPCs In Vivo
(A) Immunohistological analysis of a reporter
mouse expressing GFP under the Cpt1a promoter
reveals high GFP expression in the SGZ of the DG,
where NSPCs reside. Shown is a representative
image of a brain section from a 2-month-old
animal.
(B) Co-stainings for Cpt1a-GFP and the prolif-
eration marker Ki67 show that the majority of
proliferating NSPCs do not express GFP, sup-
porting the findings that FAO is specifically
upregulated in quiescent NSPCs. Shown is a
representative confocal image (maximum pro-
jection) from a 2-month-old Cpt1a-GFP reporter
mouse. Arrows indicate Ki67+/GFP cells; the
arrowhead points to a Ki67+/GFP+ cell. The bar
graph shows the percentage of GFP+ and GFP
NSPCs out of all Ki67+ cells in the SGZ of the
DG (mean ± SEM).
(C) Cpt1a-GFP-positive NSPCs are almost all
positive for the NSPC marker SOX2, and
GFP+ processes co-stain with the NSPC marker
Nestin. Shown is a representative confocal
image (maximum projection) from a 2-month-old
Cpt1a-GFP reporter mouse. Dotted lines show
the outline of the granular zone of the DG,
the boxed area is enlarged in the right panel.
The bar graph shows the percentage of GFP+
and GFP NSPCs out of SOX2+ cells (mean ±
SEM).
(D) Cpt1a-GFP-positive NSPCs are almost
all negative for the immature neuronal marker
Doublecortin (DCX), suggesting that FAO is
downregulated upon neuronal lineage commit-
ment. Shown is a representative confocal
image (maximum projection) from a 2-month-old Cpt1a-GFP reporter mouse. Dotted lines show the outline of the granular zone of the DG, the boxed area
is enlarged in the right panel. The bar graph shows the percentage of GFP+ and GFP NSPCs out of DCX+ cells (mean ± SEM).
Scale bars represent 200 mm (A), 50 mm (C and D, left), and 20 mm (B, C, and D, right).
See also Figure S3.
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(YFP) reporter alleles in the ROSA locus (R26YFP), inducing
recombination at seven weeks of age. The low recombination
efficiency of the S14iCre mouse line resulted in sparse labeling
of cells, allowing the identification and classification of labeled
progeny into potential clones according to their spatial clus-
tering, similarly to previously published analyses referred to as
clonal analysis (Bonaguidi et al., 2011). However, it needs to
be noted that the classification of cellular clusters into clones
according to spatial distance only assumes common lineage
and does not ultimately prove the presence of cells of clonal
origin as this would require an additional level of genetic lineage
tracing (e.g., through genetic bookmarking as previously used in
NSPCs; Fuentealba et al., 2015).
We first analyzed cell cluster size distribution 8 days after the
first TAM administration using the sparse labeling method and
found that size and composition of cellular clusters was not
significantly altered between control and Cpt1a-cKO mice,
although no larger clones were found in Cpt1a-cKO (Figures
S4A and S4D). At this time point, slightly lower numbers of clus-
ters were found in Cpt1a-cKO mice compared to control mice
(17 clones in 5 mice versus 24 clones in 4 mice), but the number
of YFP-positive cells per mouse was not significantly lower in the
Cpt1a-cKO mice compared to control mice (7.2 ± 4.5 versus 11
± 3.7; p > 0.1). Detailed cluster analysis did not reveal significant
changes (Figures S4B, S4C, and S4F), although a small decrease
in clones containing only R and a small, non-significant increase
in active clones in Cpt1a-cKO might be suggestive of an initial
activation upon Cpt1a-dependent knockout of FAO.
Next, we analyzed cell cluster composition and number
25 days after the first TAM administration. These analyses
revealed a dramatic decrease in the number of YFP-positive
cells per clone in Cpt1a-cKO mice compared to control litter-
mates (Figures 4A, 4B, and S4E). The majority of clones in the
Cpt1a-cKO mice contained only one to two cells, whereas
more than half of the clones in control mice were composed of
three to 12 or even more cells (Figures 4A, 4B, and S4E), sug-
gesting a massive impairment of NSPC expansion upon FAO
knockout. Furthermore, fewer clones were found in Cpt1a-cKO
mice compared to control mice (34 clones in seven Cpt1a-cKO
mice versus 62 clones in three control mice), and the number
of YFP-positive cells per mouse was significantly lower in the
Cpt1a-cKO mice compared to control mice (Cpt1a-cKO:
12.8 ± 5.8 versus 111 ± 65.6 in control mice; p < 0.05), implying
that FAO knockout leads to cell death. This was also reflected by
a decrease in the number of radial-glia like NSPCs in Cpt1a-cKO
compared to controls (Cpt1a-cKO: 2.6 ± 1.5 versus 17 ± 10.4 in
control mice; p = 0.06).
A detailed analysis of the clone compositions revealed an
increase in clones containing only one radial glia-like cell (R), a
reduction in clones containing an R and neural progeny (N), an
absence of clones containing a R, N and astrocytes (A), and an
increase in clones without a R in Cpt1a-cKO mice compared
to controls. Further, there was a strong reduction in the number
of active clones (containing a radial glia-like cell that generated
progeny) (Figures 4C–4D). Thus, genetic inhibition of FAO in
adult hippocampal NSPCs results in fewer recombined cells
indicative of cell death and smaller as well as less active clones
indicative of reduced cell proliferation, thus corroborating the
in vitro results upon FAO inhibition. However, the detailed impact
of FAO on the specific cellular stage (quiescence, proliferation,
cell death, and survival) cannot be answered unambiguously
with these snapshot data. Given that FAO is used by both prolif-
erating and quiescent NSPCs in vitro (although the latter have
much higher FAO levels and dependmore on it), it is indeed likely
that the strong decrease in progeny generation upon FAO abla-
tion is due to an influence of FAO on several cellular stages.
Small hairpin RNA (shRNA)-mediated knockdown of Cpt1a
using in utero electroporation in the developing mouse cortex
at mid-neurogenesis (embryonic day 13 [E13]) corroborated
the importance of FAO for proper neurogenesis in vivo that has
been also previously shown by Xie et al. (2016) (Figures S4I
and S4J). Although NSPCs are more proliferative at this stage
compared to adulthood (Farkas and Huttner, 2008), staining
against endogenous Cpt1a confirmed that Cpt1a is also highly
enriched in NSPCs lining the ventricle during development (Fig-
ure S4H). 24 hours after electroporation (corresponding to E14)
(Figure S4J), proliferation at the apical surface was significantly
reduced upon Cpt1a knockdown, and general disorganization
of mitoses in the ventricular zone was observed (Figures S4K
andS4L). Furthermore, we found amassive increase in cell death
upon Cpt1a knockdown, as measured by the apoptotic marker
cleaved caspase-3 (Figure S4M), corroborating the in vitro
results.
Malonyl-CoA Levels Regulate NSPC Proliferation
Given the important role of FAO for NSPCs in vitro and in vivo,
determined by fully blocking this pathway with genetic and
pharmacological means, we next aimed to test the significance
of this regulatory pathway for NSPC activity in a more physio-
logical manner. Metabolic pathways are finely tunable through
substrate availability and intrinsic levels of metabolites have
been shown to determine pathway activity. Such shifts in
pathway activity are likely to reflect better the actual physiolog-
ical situation than switching off a pathway by genetic deletion of
its key players. For FAO, the metabolite malonyl-CoA functions
as the endogenous inhibitor of Cpt1a and serves at the same
time as a substrate for de novo lipogenesis, thus it has also
been termed a ‘‘rheostat’’ regulating these two lipid metabolic
pathways (Foster, 2012; McGarry and Brown, 1997). Thus, we
reasoned that elevating levels of malonyl-CoA decreases
Cpt1a-dependent FAO in a physiological way rather than
completely blocking it and provides sufficient substrate to fuel
FASN-dependent de novo lipogenesis that is required for
NSPC proliferation (Knobloch et al., 2013). However, it is not
known if malonyl-CoA can be taken up by cells when provided
extracellularly. Thus, we first tested if exogenously provided
malonyl-CoA can be metabolized and detected intracellularly.
We isolated lipids of proliferating, highly lipogenic NSPCs
(Knobloch et al., 2013) that were incubated with radioac-
tively labeled malonyl-CoA (14C-malonyl-CoA) for 48 hr (Fig-
ure S5A). We detected incorporation of 14C-malonyl-CoA in
polar lipids and triacylglycerides (TAGs, neutral lipids) (Fig-
ure S5B), clearly showing that exogenous malonyl-CoA
can indeed be utilized by NSPCs. Next, we tested if exoge-
nously applied malonyl-CoA could prevent BMP4-mediated in-
duction of NSPC quiescence. Adult NSPCs were exposed to
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BMP4-containing medium in the presence of different concen-
trations of malonyl-CoA (Figure 5A). Indeed, elevated levels of
malonyl-CoA dose-dependently prevented the induction of
quiescence, as measured using the cell cycle markers Ki67
and phosphorylated histone H3 (pH3) (Figure 5B). These data
show that manipulating FAO through malonyl-CoA levels is
Figure 4. Cpt1a Is Required for Proper Neurogenesis In Vivo
(A) Conditional Cpt1a knockout in adult quiescent NSPCs, by crossing Cpt1a flox/flox mice with Spot14-driven CreERT2 recombinase mice and ROSA YFP
reporter mice, leads to disturbed neurogenesis. Shown are representative confocal images (maximum projection) and a composite image showing the recon-
struction of individual clones fromCpt1a-cKOwild-type (WT)/WTmice (left) and Cpt1a-cKO flox/floxmice (right) 25 days after first TAM induction. The boxed area
is enlarged in the reconstruction panel.
(B) Clonal analysis reveals marked reduction in clone size in the Cpt1a-cKO flox/flox mice compared to Cpt1a-cKO WT/WT littermates.
(C) Detailed clone composition analysis shows a marked increase in clones containing only one radial glia-like cell (R), a great reduction in clones containing an
R and neural progeny (N), absence of clones containing anR, N, and astrocytes (A) and a slight increase in cloneswithout an R in Cpt1a-cKO flox/flox compared to
Cpt1a-cKO WT/WT.
(D) Active clones containing a radial glia-like cell (R) and any kind of progeny (X) are strongly reduced in Cpt1a-cKO flox/flox, suggesting that FAO is required to
allow proper neurogenesis.
(E) Representative confocal images of different types of recombined, YFP-positive cells from Cpt1a cKOWT/WTmice 25 days after the first TAM injection. Radial
glia-like cells (R) have a triangular-shaped soma (arrowhead) in the subgranular zone (SGZ) with a radial, arborized process into GCL (arrow) and are SOX2
positive. Neural progenitors (N) are non-radial cells with their soma in the SGZ (arrowhead), with one or more horizontal processes (arrows), sometimes still SOX2,
some already DCX positive. Immature neurons (N) have a round soma (arrowheads) in the granular cell layer (GCL) with a long vertical process (arrow), and are
usually DCX positive. Astrocytes (A) are multi-process-containing, star-shaped or bushy cells in the SGZ/Hilus or GCL.
Scale bars represent 50 mm (A) and 40 mm (E). nd, not detected. ***p < 0.001; **p < 0.01, +p = 0.086.
See also Figure S4.
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sufficient to override BMP4-induced quiescence and keeps
NSPCs in a proliferating state.
Next, we induced BMP4-mediated quiescence over 3 days,
after which proliferation is almost completely inhibited, fol-
lowed by replating the cells in quiescence medium together
with malonyl-CoA (Figure 5C). Strikingly, we found that
malonyl-CoA triggered NSPCs to enter the cell cycle in a
dose-dependent manner, despite a fully established quies-
cence state and the continuous presence of quiescence cues
(Figure 5D). This increased proliferation is most likely mediated
by an increase in FASN-dependent de novo lipogenesis, as
the addition of the FASN inhibitor Orlistat (Kridel et al., 2004)
into the BMP4-containing quiescence medium significantly
reduced remaining proliferation and abolished the pro-prolifer-
ative effect of malonyl-CoA when applied together with ma-
lonyl-CoA (Figures S5C and S5D). These data reveal that differ-
ential metabolic states are not a mere consequence of a given
stem cell state but that manipulating levels of FAO through
Figure 5. Malonyl-CoA Levels Regulate NSPC Proliferation
(A–E) Manipulating the levels of the physiological, intrinsic Cpt1a inhibitor malonyl-CoA is sufficient to prevent NSPC quiescence and to induce proliferation under
quiescence conditions.
(A) Schematic outline of the experimental setup.
(B) Addition of malonyl-CoA (100 or 200 mM) at the beginning of quiescence induction is sufficient to prevent quiescence entry in a dose-dependent manner, as
revealed with the cell cycle marker Ki67 and the mitotic marker phospho Histone 3 (pH3). Shown are representative images of indicated doses and the quan-
tification of cycling and proliferating cells after 3 days of quiescence induction (mean ± SEM).
(C) Schematic outline of the experimental setup.
(D) Replating NSPCs after fully established quiescence in quiescence medium containing malonyl-CoA (100 or 200 mM) is sufficient to trigger cell cycle re-entry.
This suggests that malonyl-CoA levels can overrule the present quiescence cues. Shown are representative images of indicated doses and the quantification of
cycling and proliferating cells after three days of quiescence induction (mean ± SEM).
(E) Summary scheme of the described findings.
Scale bars represent 50 mm. ***p < 0.001; **p < 0.01, +p = 0.06.
See also Figure S5.
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malonyl-CoA is instructive to regulate the behavior of adult
NSPCs (Figure 5E).
DISCUSSION
Due to its significance for brain function, understanding the
mechanisms regulating adult hippocampal neurogenesis is
important to advance the current knowledge of brain plasticity
in health and disease (Jessberger and Gage, 2014). In addition
to candidate-based approaches testing the role of well-studied
signaling pathways that had been implicated in regulating
embryonic neurogenesis such as Notch- and WNT-signaling, a
series of recent studies used unbiased approaches to charac-
terize gene expression profiles during distinct developmental
stages in the course of adult neurogenesis (Bracko et al., 2012;
Llorens-Bobadilla et al., 2015; Shin et al., 2015). These studies
all pointed toward an important role of cellular metabolism
and, more specifically, lipid metabolism in the regulation of the
neurogenic process in the adult brain. Supporting this, we
have previously shown that NSPCs in the adult brain depend
on FASN-dependent de novo lipogenesis for proper proliferation
and have identified Spot14, which is selectively expressed in
largely quiescent NSPCs, as the brake on de novo lipogenesis
(Knobloch et al., 2013, 2014). However, it remained unclear if
Spot14 merely suppresses de novo lipogenesis to keep NSPCs
in a quiescence state or if NSPC quiescence requires a special-
ized metabolic state.
We here used several complementary approaches in vitro
and in vivo to show that quiescent NSPCs rely on FAO and
that blocking this pathway pharmacologically or genetically
leads to massive disturbance of NSPC behavior. Using
in vitro approaches, we find clear evidence that inhibition of
FAO leads to enhanced cell death of quiescent cells but also
reduced proliferation. The conditional deletion of the rate-
limiting enzyme Cpt1a in vivo also results in fewer and smaller
cellular clusters, suggesting that the role for FAO in vivo resem-
bles the described function of cultured NSPCs in vitro. The
conditional deletion of Cpt1a in quiescent Spot14-positive
NSPCs using the Spot14-CreERT2 mouse line allowed us to
study the role of FAO on a specific NSPC population, reducing
possible side effects of altering FAO in astrocytes, as would
be the case by using other Cre-lines, such as GLAST-CreERT2
or Nestin-CreERT2 (Lagace et al., 2007; Mori et al., 2006).
However, the low recombination efficiency of the Spot14-
CreERT2-line results in sparse labeling, enabling clonal analysis,
but making assessments of proliferation or cell death with clas-
sical markers almost impossible. Thus, the detailed cellular ef-
fects (i.e., on exactly which stage FAO deletion exerts its main
phenotype) remain to be elucidated and will require novel ap-
proaches to study neurogenesis within the endogenous niche
such as chronic imaging.
Although glucose and lactate remain the main fuel sources
for the brain (Lundgaard et al., 2015; Wyss et al., 2011), our
data suggest that NSPCs might not only rely on these fuels.
We provide mechanistic evidence that oxidized fatty acids
are required for energy production and might serve as an alter-
native carbon source. Thus, our data reveal a metabolic shift in
adult hippocampal NSPCs that defines the change from a
quiescent to a proliferative state. Interestingly, many metabolic
pathways are not only transcriptionally regulated but also high-
ly dependent on substrate availability and inhibitory feedback
loops of metabolic intermediates, providing a regulatory sys-
tem than can be finely tuned rather than an ‘‘on-off’’ system
(Lunt and Vander Heiden, 2011; Metallo and Vander Heiden,
2013). This is also the case for the breakdown and buildup of
lipids (Houten et al., 2016; Menendez and Lupu, 2007). A cen-
tral role in regulating the shift from FAO to lipogenesis appears
to be mediated by the levels of malonyl-CoA. This physiological
metabolite has been suggested to be a rheostat of stem cell
fate (Folmes et al., 2013), being both an inhibitor of Cpt1a
and a substrate for de novo lipogenesis (McGarry et al.,
1983; Menendez and Lupu, 2007). Strikingly, we have previ-
ously shown that Spot14, which is highly expressed in quies-
cent NSPCs, indirectly reduces the levels of available
malonyl-CoA and reduces lipid synthesis (Knobloch et al.,
2013). BMP4-induced quiescent NSPCs recapitulate these fea-
tures and show highly increased Spot14 levels and reduced
malonyl-CoA levels, providing optimal conditions for FAO.
Thus, our data support the hypothesis that malonyl-CoA acts
as a rheostat with Spot14 taking a key role in this regulatory
process (summarized in the graphical abstract). Our data
corroborate previous findings by Stoll and colleagues who
characterized the metabolic state of NSPCs in the subventric-
ular zone (SVZ) and found that NSPCs in the adult SVZ depend
on FAO for their proliferation as shown by infusing Etomoxir
(thus pharmacologically inhibiting FAO) into the adult brain
(Stoll et al., 2015). Interestingly, recent studies described a
role for FAO in other stem cell systems: hematopoietic stem
cells (HSCs) seem to require FAO to maintain their stem cell
potential through a PPAR-delta mediated pathway and inhibi-
tion of FAO leads to HSC exhaustion (Ito et al., 2012). Similarly,
quiescent muscle satellite cells are relying on FAO and pyru-
vate oxidation and undergo a metabolic shift toward glycolysis
once they become activated (Ryall et al., 2015). Furthermore, a
recent study has addressed the consequences of systemic
inborn errors of FAO on brain development and showed that
defects in FAO lead to enhanced progenitor generation and
subsequently to a reduced embryonic NSPC pool (Xie et al.,
2016). These studies emphasize the importance of FAO for
proper stem cell behavior and suggest shared regulatory path-
ways involving FAO between different somatic stem cell types.
Whether malonyl-CoA levels and Spot14 are the regulating
entities in other somatic stem cells remains to be elucidated.
Excitingly, our data show thatmetabolic changes in the course
of NSPC activation are not mere bystanders of other signaling
pathways or transcriptional programs, but are effective to
change NSPC behavior in vitro. Manipulating FAO through
changing the levels of a single metabolite, its endogenous inhib-
itor malonyl-CoA, is sufficient to instruct quiescent NSPCs to
enter cell cycle and to proliferate in vitro. Due to the short half-
life of malonyl-CoA at 37C (72 hr), in vivo experiments are
currently not feasible. In contrast to the detrimental effects
seen when completely switching off FAO genetically or pharma-
cologically, alteration of endogenous metabolite levels might
better reflect the physiological relevance of metabolic shifts.
Given the instructive role of metabolism on NSPC quiescence
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and proliferation behavior, manipulations of the metabolic state
may thus represent a novel approach to achieve enhanced
neurogenesis in the aging brain or in disease states where
NSPC activity is reduced.
EXPERIMENTAL PROCEDURES
Further details and an outline of the resources used in this work can be found in
the Supplemental Experimental Procedures.
Mouse strains used were Cpt1a-EGFP reporter mice (STOCK Tg(Cpt1a-
EGFP)IP41Gsat/Mmucd, MMRRC), Cpt1a cKO mice (Schoors et al., 2015),
Spot14CreERT2 mice (S14iCre) Knobloch et al., 2013), ROSA26 YFP reporter
mice (R26YFP), and C57/Bl6 mice (Janvier). All animal experiments were per-
formed according to Swiss regulatory standards and approved by the Veteri-
nary office of the Canton of Zurich. Cre-mediated recombination was induced
by intraperitoneal injections of tamoxifen (180 mg/kg) at the age of 6 to
7 weeks. Lentiviral constructs were designed and viruses produced as previ-
ously described (Knobloch et al., 2013). Adult mouse DGNSPCswere cultured
in DMEM with Ham’s F12, supplemented with N2 supplement plus epidermal
growth factor (EGF), fibroblast growth factor, and heparin (Knobloch et al.,
2013; Ray and Gage, 2006). Quiescence was induced over three days replac-
ing EGF with BMP4, as previously described (Martynoga et al., 2013; Mira
et al., 2010). For Cpt1a inhibition, Etomoxir or malonyl-CoA was added to
the medium as outlined in the figures. Proteomic analysis was done according
to previously established protocols (Wisniewski et al., 2009). Radioactive FAO
measurements were done using labeled 3H-palmitic acid and 14C-palmitic
acid, and the amount of tritiated water or 14CO2 generated was assessed
(Djouadi et al., 2003; Huynh et al., 2014). Quiescent and proliferating NSPCs
were collected for RNA and protein isolation, and established protocols
were used for subsequent processing and analysis (Knobloch et al., 2013).
In utero electroporation of Cpt1a and control shRNA plasmid DNA into mouse
embryos (embryonic day 13 [E13]) was carried out as described previously
(Asami et al., 2011). For immunohistochemical analyses, brain tissues were
sectioned, stained, and imaged using previously published methods (Bona-
guidi et al., 2011; Knobloch et al., 2013). Mass spectrometry measurements
to assess the amount of malonyl-CoA and to determine the energy charge
were done with cellular extracts using liquid chromatography-tandem mass
spectrometry LC-MS/MS (Knobloch et al., 2013; Schoors et al., 2015). To
analyze C13 incorporation, quiescent and proliferating NSPCs were incubated
24 hr prior to collection/extraction with 13C-palmitic acid and analyzed with
gas chromatography-mass spectrometry (GC-MS) as previously described
(Schoors et al., 2015). Statistical analysis was performed using unpaired
t tests, paired t tests, and one-way-ANOVA or two-way-ANOVA, followed by
Holm-Sidak’s multiple comparisons tests. Significance levels are set at
p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2017.08.029.
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